OLAMKICEPT (sgp130Fc) DEMONSTRATES TARGET ENGAGEMENT AND INTERLEUKIN-6 PATHWAY INHIBITION ASSOCIATED WITH CLINICAL EFFECTIVENESS IN AN OPEN LABEL TRIAL (FUTURE) IN ACTIVE IBD

Stefan Schreiber  1     Konrad Aden  2     Claudio Conrad  3     Joana P. Bernardes  4     Johannes Bethge  5     Florian Tran     Hanna Hoeper     Susanna Nikolaus     Christoph Röcken     Ian Cottingham     Birgitte Rasmussen     Niclas Petri     Georg H Waetzig     Minhun Chen     Philip Rosenstiel    
1 Universität Kiel UKSH Medizinische Abt. I - UKSH, Universität Kiel UKSH Medizinische Abt. I,Kiel,Germany
2 IKMB + First Medical Department,Kiel,Germany
3 Univers.-Klinik Schleswig-Holstein,Kiel,Germany
4 Institute of Clinical Molecular Biology Christian-Albrechts-University of Kiel,Kiel,Germany
5 UKSH Kiel,Kiel,Germany

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing